News & Events about Hologic Inc.
StockNews.com downgraded shares of Hologic (NASDAQ:HOLX Get Rating) from a buy rating to a hold rating in a research report released on Wednesday morning. HOLX has been the subject of several other reports. JPMorgan Chase & Co. upped their price target on shares of Hologic from $90.00 to $95.00 and ...
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire VANCOUVER, British Columbia, March 24, 2023 FN Media Group Presents USA News Group News Commentary VANCOUVER...
The Online Investor
2 months ago
A study of analyst recommendations at the major brokerages shows that Hologic Inc (HOLX) is the #104 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over ...
Business Wire
3 months ago
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Court of Appeals for the Federal Circuit unanimously affirmed a 2021 district court ruling that invalidated a Minerva patent asserted against Hologic. The appellate court ruled that Minervas patent is invalid because it waited more than a...